Avecia sells off nitroglycerin business

Manchester, UK-based Avecia has sold off its Special Drug Mixtures
subsidiary to Copperhead Chemical of the US.

The SDM business is focused on the production of a line of standard and custom nitroglycerin mixtures, which are used in the treatment of angina and congestive heart failure.

"Copperhead Chemical is the exclusive manufacturer of the active ingredient nitroglycerin used by the SDM business, and this acquisition will bring us closer to the customer base that we have served indirectly for many years,"​ said Eric Brooks, president of the US company.

In addition to the SDM business, Copperhead is a current Good Manufacturing Practice-approved custom manufacturer of various specialty products, including microencapsulated food ingredients and specialty laboratory chemicals.

It also makes energetic ingredients for use in propellants and munitions for the defence and commercial markets.

For Avecia, the sale somes after a series of divestments - notably of its additives and biocides businesses - as it focuses on its core cabalities in chemicals, biotechnology and resins.

Related news

Show more

Related products

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Follow us


View more